Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
753 | 3021 | 49.8 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IL 17 | Author keyword | 192 | 38% | 14% | 408 |
2 | INTERLEUKIN 17 | Author keyword | 143 | 42% | 9% | 267 |
3 | TH17 | Author keyword | 91 | 27% | 9% | 286 |
4 | TH17 CELLS | Author keyword | 62 | 31% | 5% | 164 |
5 | IL 23 | Author keyword | 55 | 35% | 4% | 126 |
6 | IL 17F | Author keyword | 44 | 70% | 1% | 37 |
7 | IL 17A | Author keyword | 42 | 40% | 3% | 81 |
8 | INTERLEUKIN 23 | Author keyword | 31 | 37% | 2% | 67 |
9 | ROR GAMMA T | Author keyword | 23 | 47% | 1% | 37 |
10 | INTERLEUKIN 17F | Author keyword | 22 | 81% | 0% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IL 17 | 192 | 38% | 14% | 408 | Search IL+17 | Search IL+17 |
2 | INTERLEUKIN 17 | 143 | 42% | 9% | 267 | Search INTERLEUKIN+17 | Search INTERLEUKIN+17 |
3 | TH17 | 91 | 27% | 9% | 286 | Search TH17 | Search TH17 |
4 | TH17 CELLS | 62 | 31% | 5% | 164 | Search TH17+CELLS | Search TH17+CELLS |
5 | IL 23 | 55 | 35% | 4% | 126 | Search IL+23 | Search IL+23 |
6 | IL 17F | 44 | 70% | 1% | 37 | Search IL+17F | Search IL+17F |
7 | IL 17A | 42 | 40% | 3% | 81 | Search IL+17A | Search IL+17A |
8 | INTERLEUKIN 23 | 31 | 37% | 2% | 67 | Search INTERLEUKIN+23 | Search INTERLEUKIN+23 |
9 | ROR GAMMA T | 23 | 47% | 1% | 37 | Search ROR+GAMMA+T | Search ROR+GAMMA+T |
10 | INTERLEUKIN 17F | 22 | 81% | 0% | 13 | Search INTERLEUKIN+17F | Search INTERLEUKIN+17F |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERLEUKIN 17 | 302 | 45% | 17% | 510 |
2 | IL 17 | 298 | 45% | 17% | 504 |
3 | TH17 CELLS | 256 | 30% | 24% | 728 |
4 | AUTOIMMUNE INFLAMMATION | 175 | 46% | 9% | 286 |
5 | ROR GAMMA T | 134 | 33% | 11% | 331 |
6 | INTERLEUKIN 17 RECEPTOR | 110 | 93% | 1% | 41 |
7 | IL 23 | 110 | 39% | 7% | 221 |
8 | IL 17 RECEPTOR | 75 | 71% | 2% | 61 |
9 | HUMAN TH17 CELLS | 58 | 47% | 3% | 91 |
10 | IL 17 PRODUCING T CELLS | 51 | 47% | 3% | 80 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
IL-17 and Th17 Cells | 2009 | 1594 | 221 | 50% |
Th17 and regulatory T cell balance in autoimmune and inflammatory diseases | 2014 | 47 | 86 | 57% |
Targeting IL-17and T(H)17 cells in chronic inflammation | 2012 | 180 | 160 | 71% |
Functional Specialization of Interleukin-17 Family Members | 2011 | 275 | 137 | 66% |
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing | 2014 | 38 | 174 | 57% |
Interleukin-17 family members and inflammation | 2004 | 1096 | 76 | 84% |
Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis | 2014 | 22 | 64 | 83% |
Anti-IL-17 phase II data for psoriasis: A review | 2015 | 3 | 30 | 70% |
Th17 Cells Biology, Pathogenesis of Autoimrnune and Inflammatory Diseases, and Therapeutic Strategies | 2012 | 140 | 108 | 60% |
Essentials of Th17 cell commitment and plasticity | 2013 | 66 | 195 | 47% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPT PATHOL PHARMACOL | 8 | 50% | 0.4% | 12 |
2 | IMMUNOL CELLULAR THER Y UNIT | 6 | 80% | 0.1% | 4 |
3 | IMMUNOGENOM INFLAMMAT UNIT | 4 | 67% | 0.1% | 4 |
4 | DNAX DISCOVERY | 4 | 75% | 0.1% | 3 |
5 | EXCELLENCE TRANSFER HIGH EDUC DEV N | 3 | 100% | 0.1% | 3 |
6 | LUNG IMMUNOL HOST DEF | 3 | 100% | 0.1% | 3 |
7 | LOUISIANA CANC CONSORTIUM | 3 | 35% | 0.2% | 7 |
8 | TULANE STEM CELL REGENERAT MED | 3 | 35% | 0.2% | 7 |
9 | MOL IMMUNOL INFLAMMAT BRANCH | 3 | 13% | 0.7% | 22 |
10 | HOLTOM GARRETT PROGRAM NEUROIMMUNOL | 3 | 31% | 0.3% | 8 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000155825 | IL 27//INTERLEUKIN 27//IL 35 |
2 | 0.0000150104 | IL 24//MDA 7//IL 22 |
3 | 0.0000094474 | ROR ALPHA//TH17 CELL DIFFERENTIATION//ROR GAMMA |
4 | 0.0000092096 | IL 9//INTERLEUKIN 9//MAGAININ MOL MED |
5 | 0.0000089525 | INTERLEUKIN 21//IL 21//FOLLICULAR HELPER T CELLS |
6 | 0.0000086745 | T BET//GATA 3//HELPER T CELL DIFFERENTIATION |
7 | 0.0000079458 | CCL20//CCR6//MACROPHAGE INFLAMMATORY PROTEIN 3 ALPHA |
8 | 0.0000062637 | IL 33//INTERLEUKIN 33//ST2 |
9 | 0.0000058565 | HANS WILSDORF//CLIN IMMUNOL UNITHANS WILSDORF//IMMUNOL ALLERGYCLIN IMMUNOL UNIT |
10 | 0.0000058186 | FOXP3//REGULATORY T CELLS//REGULATORY T CELL |